Management of hyperkalaemia in adults

Ulster Medical Journal

Volumn 74, Issue 2, 2005, Pages 75-77

  McVeigh, G ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMILORIDE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BICARBONATE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUCONATE CALCIUM; GLUCOSE; HEPARIN; INSULIN; NEUTRAL INSULIN; NONSTEROID ANTIINFLAMMATORY AGENT; POLYSTYRENESULFONATE CALCIUM; POTASSIUM; POTASSIUM ION; POTASSIUM SPARING DIURETIC AGENT; SPIRONOLACTONE; SUXAMETHONIUM;

ADULT; CLINICAL TRIAL; COMORBIDITY; DIABETES MELLITUS; ECG ABNORMALITY; HEART ARREST; HEART DISEASE; HEART FAILURE; HEMODIALYSIS; HOSPITALIZATION; HUMAN; HYPERKALEMIA; HYPOGLYCEMIA; INCIDENCE; KIDNEY FAILURE; NOTE; P WAVE; POTASSIUM BLOOD LEVEL; PRESCRIPTION; QRS COMPLEX; RISK FACTOR;

ADULT; HEART ARREST; HUMANS; HYPERKALEMIA; PRACTICE GUIDELINES;

EID: 26844522817     PISSN: 00416193     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (9)

1. Moore ML, Bailey RR. Hyperkalaemia in patients in hospital. N Z Med J 1989; 102(878): 557-8.
2. Acker CG, Johnson JP, Palevsky PM, Greenberg A. Hyperkalemia in hospitalized patients: causes, adequacy of treatment, and results of an attempt to improve physician compliance with published therapy guidelines. Arch Intern Med 1998; 158(8): 917-24.
3. Mahoney BA, Smith WA, Lo DS, Tsoi K, Tonelli M, Clase CM. Emergency interventions for hyperkalaemia. Cochrane Database Syst Rev 2005; 18(2): CD003235. http:www.thecochranelibrary.com
4. Webster A, Brady W, Morris F. Recognising signs of danger: ECG changes resulting from an abnormal serum potassium concentration. Emerg Med J 2002; 19(1): 74-7.
5. Davey M. Calcium for hyperkalaemia in digoxin toxicity. Emerg Med J 2002; 19(2): 183.
6. Ramrakha P, Moore K. Oxford Handbook of Acute Medicine 2nd Ed. Oxford University Press 2004: pp384.
7. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl Med 1999; 341(10): 709-17.
8. Gross P, Pistrosch F. Hyperkalaemia: again. Nephrol Dial Transplant 2004; 19: 2163-66.
9. CREST. Guidelines for the treatment of Hyperkalaemia in adults. Available from http://www.crestni.org.uk/hyperkalaemia_booklet.pdf